A Multicenter Randomized Doubleblind Vehicle-controlled Parallel Comparison Study to Determine Therapeutic Equivalence of Generic Ingenol Mebutate Gel 0.015% and Picato® Gel 0.015% in Subjects With Actinic Keratosis on the Face or Scalp
Phase: PHASE3
Conditions: ACTINIC KERATOSIS
Sponsor: Actavis Inc.

 
 
 
A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, PARALLEL 
GROUP COMPARISON STUDY TO DETERMINE THE THERAPEUTIC EQUIVALENCE OF A 
GENERIC INGENOL MEBUTATE GEL, 0.015% AND PICATO® GEL, 0.015% IN SUBJECTS WITH 
ACTINIC KERATOSIS ON THE FACE OR SCALP 
 
 
 
NCT03200912 
 
 
 
 
Protocol dated: May 26, 2016